Active Funding Opportunities - click the links below:

Parexel - Recurrent C. Diff. Infection

Bioequivalence Anesthetics Studies - ISS Opportunity Notice #4275

Phase 3 Triple Negative Breast Cancer Studies - ISS Opportunity Notice #4280

Study Opportunity: Type 2 Diabetes and Chronic Kidney Disease

Study Opportunity- Non-small cell Lung Cancer

Study Opportunity- Chronic Obstructive Pulmonary Disease (COPD)

Study Opportunity - Ischemic Stroke

Study Opportunity - B-Cell Chronic Lymphocytic Leukemia

Study Opportunity - Chronic Inflammatory Demyelinating Polyneuropathy

Actimed Therapeutics Cancer Cachexia clinical trials

Advanced Solid Tumors

Phase Ib/II Advanced/Metastatic Ovarian or Endometrial Cancer

Clinical Trial Opportunity: Lung Cancer

Study Opportunity Phase I Heart Failure study

Non-Interventional (NIS) post-market clinical study to collect safety and performance data on Johnson & Johnson Surgical Vision products

Clinical Trial Opportunity: Diabetic Foot Ulcers

Clinical Trial Opportunity: Diffuse Large B-Cell Lymphoma in Minority Populations

Study Opportunity: Major Bleeding in Patients Treated with Factor Xa Inhibitors

Recurrent C. Diff. infection

Phase 2 Asthma Studies

Major Bleeding in Patients Treated with Factor Xa Inhibitors

Clinical Trial Opportunity: Lung Cancer

Epilepsy Research Program Anticipated Funding Opportunities for Fiscal Year 2024 (FY24)

Breast Cancer Research Program Anticipated Funding Opportunity for Fiscal Year 2024 (FY24)

Clinical Trial Opportunity : Heart Failure